556 related articles for article (PubMed ID: 27686492)
61. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
62. Limited N-Glycan Processing Impacts Chaperone Expression Patterns, Cell Growth and Cell Invasiveness in Neuroblastoma.
Hall MK; Shajahan A; Burch AP; Hatchett CJ; Azadi P; Schwalbe RA
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829569
[TBL] [Abstract][Full Text] [Related]
63. Galectin-Binding O-Glycosylations as Regulators of Malignancy.
Dimitroff CJ
Cancer Res; 2015 Aug; 75(16):3195-202. PubMed ID: 26224120
[TBL] [Abstract][Full Text] [Related]
64. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
65. CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation.
Rømer TB; Khoder-Agha F; Aasted MKM; de Haan N; Horn S; Dylander A; Zhang T; Pallesen EMH; Dabelsteen S; Wuhrer M; Høgsbro CF; Thomsen EA; Mikkelsen JG; Wandall HH
Glycobiology; 2023 Oct; 33(9):700-714. PubMed ID: 36648436
[TBL] [Abstract][Full Text] [Related]
66. Importance of N-glycosylation on CD147 for its biological functions.
Bai Y; Huang W; Ma LT; Jiang JL; Chen ZN
Int J Mol Sci; 2014 Apr; 15(4):6356-77. PubMed ID: 24739808
[TBL] [Abstract][Full Text] [Related]
67. In silico simulation of glycosylation and related pathways.
Akune-Taylor Y; Kon A; Aoki-Kinoshita KF
Anal Bioanal Chem; 2024 Jul; 416(16):3687-3696. PubMed ID: 38748247
[TBL] [Abstract][Full Text] [Related]
68. Insights into miRNA regulation of the human glycome.
Kasper BT; Koppolu S; Mahal LK
Biochem Biophys Res Commun; 2014 Mar; 445(4):774-9. PubMed ID: 24463102
[TBL] [Abstract][Full Text] [Related]
69. Protein glycosylation in cancer.
Stowell SR; Ju T; Cummings RD
Annu Rev Pathol; 2015; 10():473-510. PubMed ID: 25621663
[TBL] [Abstract][Full Text] [Related]
70. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease.
Tang X; Tena J; Di Lucente J; Maezawa I; Harvey DJ; Jin LW; Lebrilla CB; Zivkovic AM
Sci Rep; 2023 May; 13(1):7816. PubMed ID: 37188790
[TBL] [Abstract][Full Text] [Related]
71. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.
Pinho SS; Alves I; Gaifem J; Rabinovich GA
Cell Mol Immunol; 2023 Oct; 20(10):1101-1113. PubMed ID: 37582971
[TBL] [Abstract][Full Text] [Related]
72. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
Potapenko IO; Haakensen VD; Lüders T; Helland A; Bukholm I; Sørlie T; Kristensen VN; Lingjaerde OC; Børresen-Dale AL
Mol Oncol; 2010 Apr; 4(2):98-118. PubMed ID: 20060370
[TBL] [Abstract][Full Text] [Related]
73. Glycosylation pathways as drug targets for cancer: glycosidase inhibitors.
Gerber-Lemaire S; Juillerat-Jeanneret L
Mini Rev Med Chem; 2006 Sep; 6(9):1043-52. PubMed ID: 17018003
[TBL] [Abstract][Full Text] [Related]
74. Altered tumor-cell glycosylation promotes metastasis.
Häuselmann I; Borsig L
Front Oncol; 2014; 4():28. PubMed ID: 24592356
[TBL] [Abstract][Full Text] [Related]
75. What Have We Learned from Glycosyltransferase Knockouts in Mice?
Stanley P
J Mol Biol; 2016 Aug; 428(16):3166-3182. PubMed ID: 27040397
[TBL] [Abstract][Full Text] [Related]
76. Glycosylation potential of human prostate cancer cell lines.
Gao Y; Chachadi VB; Cheng PW; Brockhausen I
Glycoconj J; 2012 Oct; 29(7):525-37. PubMed ID: 22843320
[TBL] [Abstract][Full Text] [Related]
77. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
78. Harnessing changes in cellular glycosylation in new cancer treatment strategies.
Dwek MV; Brooks SA
Curr Cancer Drug Targets; 2004 Aug; 4(5):425-42. PubMed ID: 15320718
[TBL] [Abstract][Full Text] [Related]
79. Lack of complex type N-glycans lessens aberrant neuronal properties.
Hall MK; Weidner DA; Whitman AA; Schwalbe RA
PLoS One; 2018; 13(6):e0199202. PubMed ID: 29902282
[TBL] [Abstract][Full Text] [Related]
80. Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.
Boligan KF; Mesa C; Fernandez LE; von Gunten S
Cell Mol Life Sci; 2015 Apr; 72(7):1231-48. PubMed ID: 25487607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
